Rosenblatt Maintains Buy on Dolby Laboratories, Lowers Price Target to $75

Benzinga · 1d ago
Rosenblatt analyst Steven Frankel maintains Dolby Laboratories (NYSE:DLB) with a Buy and lowers the price target from $80 to $75.